Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Tiragolumab + Atezolizumab for Non-Small Cell Lung Cancer
Recruiting1 awardPhase 3
Vancouver, Washington
This trial is testing a new combination of drugs to treat lung cancer that hasn't been treated before. The drugs are tiragolumab and atezolizumab, which will be given either with or without placebo. The goal is to see if the combination of tiragolumab and atezolizumab is more effective and has fewer side effects than atezolizumab given with placebo.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service